ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED clinical trials

A phase II, national, multicenter, uncontrolled and open trial to evaluate the feasibility and safety of lamparoscopic administration of allogenic mesenchymals stem cell (adMSC) extracted by lipoaspirate from healthy patients, for the treatment of patients with inflammatory bowel strictures associated with Crohn's disease. SM

This study looks into using special cells from healthy donors to treat a problem called strictures in people with Crohn's disease. Doctors want to see if this treatment is safe and how well it works to reduce blockages in the gut.